✦ LIBER ✦

Frequency and Impact of Allogeneic Hematopoetic Stem Cell Transplant and Preparative Regimen in Patients with High and Intermediate Risk AML at a Small Center

✍ Scribed by Farhan, Shatha; Neme, Klodiana; Mikulandric, Nancy; Ruemenapp, Kenneth; Trapp, Mary Ann; Szymanski, Sarah; Peres, Edward; Janakiraman, Nalini

Book ID: 122127671
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 280 KB
Volume: 20
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2013.12.371

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of the FLT3-ITD and NPM1 Mutati

Analysis of the FLT3-ITD and NPM1 Mutations in AML Patients With Intermediate Risk Receiving Allogeneic Stem-Cell Transplantation

✍ M. Ogasawara; T. Yamakawa; Y. Katsura; K. Shima; T. Matsukawa; M. Kanaya; K. Min 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Intermediate intensity conditioning regi

Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia

✍ Jens Marcus Chemnitz; Marie von Lilienfeld-Toal; Udo Holtick; Sebastian Theurich 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 166 KB

Impact of Conditioning Regimen in Alloge

Impact of Conditioning Regimen in Allogeneic Hematopoetic Stem Cell Transplantation for Children with Acute Myelogenous Leukemia beyond First Complete Remission: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study

✍ India Y. Sisler; Elizabeth Koehler; Tatsuki Koyama; Jennifer A. Domm; Robin Ryan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 233 KB

Outcome of High-Risk and Refractory AML/

Outcome of High-Risk and Refractory AML/MDS Patients Receiving a Flamsa Sequential Chemotherapy Regimen Followed by Reduced-Intensity Conditioning (RIC) and Allogeneic Hematopoeitic Stem Cell Transplantation (allo-HSCT)

✍ M. Detrait; P. Chevallier; M. Sobh; T. Guillaume; X. Thomas; S. Morisset; N. Ted 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Low Morbidity and Mortality in a Pilot S

Low Morbidity and Mortality in a Pilot Study of Busulfan, Melphalan and Topotecan as Preparative Regimen Followed By Autologous Hematopoetic Stem Cell Transplantation In Pediatric Patients With High Risk Solid Tumors (Preliminary Results)

✍ E. Bolotin; A. Pawlowska; D. Hitt; C. Andersen; M. Shakhnovitz; J. Sato; S. Form 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

163: Clofarabine Pre-Conditioning Prior

163: Clofarabine Pre-Conditioning Prior to Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukaemia (AML): A Well Tolerated Regimen with Both Full and Reduced Toxicity Schedules

✍ D.S. Richardson; C. Hurlock; K. Hill; J. Newman; N. McKeag; L. Groves; K.H. Orch 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 49 KB